Novo Nordisk A/S Sponsored ADR (NVO)
NYSE
Closed
Oct 9, 2026
Day's Range
38.0652 wk Range
35.12Overview - NVO - Novo Nordisk A/S Sponsored ADR
Key Statistics
Valuation
Enterprise Value
39.19B
P/E (Trailing)
‪9.35‬
P/E (Forward)
‪11.12‬
PEG Ratio
‪-0.45‬
Price / Sales (TTM)
‪0.50‬
Price / Book
‪4.83‬
EV / EBITDA
‪1.49‬
Profitability
Gross Margin
‪78.21%‬
Profit Margin
‪35.34%‬
Operating Margin
‪42.54%‬
Return on Assets
‪18.72%‬
Return on Equity
‪59.81%‬
Ownership
Shares Outstanding
4.42B
Float
3.17B
Short % of Shares Outstanding
‪0.83%‬
Held by Insiders
‪0.0030%‬
Held by Institutions
‪9.89%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪44.90‬
200-Day Avg
‪45.72‬
Dividends
Payout Ratio
‪44.46%‬
Frequency
Semi-Annual
Analyst Consensus
14 analysts
Average price target
‪$ 47.38‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NVO - Novo Nordisk A/S Sponsored ADR
Peers - NVO - Novo Nordisk A/S Sponsored ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NYSE.
- NVONYSENovo Nordisk A/S Sponsored ADR164.78BMarket Cap-59.83%52-week change9.35P/E (Trailing)‪35.34%‬Profit Margin
- LLYNYSEEli Lilly and Company1.05TMarket Cap+38.61%52-week change39.69P/E (Trailing)‪33.52%‬Profit Margin
- JNJNYSEJohnson & Johnson617.00BMarket Cap+26.51%52-week change29.74P/E (Trailing)‪21.48%‬Profit Margin
- ABBVNYSEAbbVie Inc.464.43BMarket Cap+12.41%52-week change73.62P/E (Trailing)‪9.80%‬Profit Margin
- MRKNYSEMerck & Co., Inc.356.01BMarket Cap+38.46%52-week change115.98P/E (Trailing)‪4.76%‬Profit Margin
- NVSNYSENovartis AG Sponsored ADR276.47BMarket Cap+14.68%52-week change21.97P/E (Trailing)‪22.50%‬Profit Margin
- SANNYSEBanco Santander, S.A. Sponsored ADR209.19BMarket Cap+28.64%52-week change14.28P/E (Trailing)‪33.46%‬Profit Margin
Profile Summary - NVO - Novo Nordisk A/S Sponsored ADR
About
Novo Nordisk A/S Sponsored ADR is a healthcare company focused on discovering, developing, manufacturing, and marketing pharmaceutical products. The company’s current business is organized around diabetes and obesity care, where it offers treatments and related devices for chronic metabolic conditions, and rare…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
